ONCO

Onconetix, Inc.

Healthcare · Biotechnology

$47.57 sample

-0.20 (-0.42%) 1D

Market cap

$160.1B

Price as of

2026-10-15

Latest filing

8-K · 2026-09-17

Alerts

8

Price$47.57 +15.07% 3M daily closessample

48.8940.04

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 13INSInsider sell: General Counsel
Oct 06INSInsider sell: General Counsel
Sep 25INSInsider buy: General Counsel
Sep 17SECForm 144 filed
Sep 10INSInsider sell: EVP, Operations
Sep 01INSInsider buy: 10% owner
Aug 21INSInsider sell: Chief Executive Officer
Aug 13INSInsider buy: Chief Executive Officer

Sign up to see the real ONCO record →

Company facts

SEC EDGAR registration

Name: Onconetix, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -2sample, -100 to +100
Reporting currency: USD

Who is positioning in ONCO

sample

Insiders: 32 insider transactions over 90 days, net selling, $600.7M
Congress: 3 members traded over 90 days
Institutions · 13F: 8 funds hold $3.1B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$6.0B +16.5% y/y

Q4 2024Q3 2026

Inventory$3.7B +6.0% y/y

Q4 2024Q3 2026

Accounts receivable$2.8B +8.8% y/y

Q4 2024Q3 2026

Total debt$7.4B +13.2% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $48.9B -0.7% 3M
Sample peer B: $89.1B -8.0% 3M
Sample peer C: $54.5B -4.2% 3M
Sample peer D: $66.7B +11.5% 3M
Sample peer E: $76.1B +15.6% 3M